These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 3733519

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Studies on protein binding of antibiotics. II. Effect of apalcillin on protein binding and pharmacokinetics of cefoperazone and cefazolin.
    Watanabe Y, Hayashi T, Kitayama R, Yasuda T, Saikawa I, Shimizu K.
    J Antibiot (Tokyo); 1981 Jun; 34(6):753-7. PubMed ID: 6456252
    [Abstract] [Full Text] [Related]

  • 5. [Fundamental and clinical studies on imipenem/cilastatin sodium in the pediatric field].
    Toyonaga Y, Sugita M, Tsuda T, Takahashi T, Hori M.
    Jpn J Antibiot; 1986 Jul; 39(7):1765-86. PubMed ID: 3464778
    [Abstract] [Full Text] [Related]

  • 6. [Studies on tissue concentrations of cefoperazone and piperacillin classified by the site of the wall of gallbladder and concentration of piperacillin in the bile after operation].
    Shima K, Ueno K, Ooto T, Shima Y, Miyata T, Sei T, Yonemura Y, Uemura T, Takano N.
    Jpn J Antibiot; 1984 Jun; 37(6):966-72. PubMed ID: 6492387
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Comprehensive evaluation of pharmacokinetic and clinical studies on tazobactam/piperacillin in pediatric field].
    Fujii R, Okuno A, Fujita K, Yoshikawa M, Inyaku F, Takimoto M, Saijo M, Wagatsuma S, Fukushima N, Ishikawa A.
    Jpn J Antibiot; 1995 Mar; 48(3):311-45. PubMed ID: 7752448
    [Abstract] [Full Text] [Related]

  • 11. Studies on protein binding of antibiotics. I. Effect of cefazolin on protein binding and pharmacokinetics of cefoperazone.
    Watanabe Y, Hayashi T, Takada R, Yasuda T, Saikawa I, Shimizu K.
    J Antibiot (Tokyo); 1980 Jun; 33(6):625-35. PubMed ID: 6448233
    [Abstract] [Full Text] [Related]

  • 12. [Fundamental and clinical studies of sulbactam/cefoperazone in the pediatric field].
    Iwata S, Sato Y, Iwasaki Y, Hayano S, Wakabayashi R, Kojima Y, Akita H, Sunakawa K, Oikawa T, Osano M.
    Jpn J Antibiot; 1984 Oct; 37(10):1831-45. PubMed ID: 6094863
    [Abstract] [Full Text] [Related]

  • 13. [Laboratory and clinical studies on cefoperazone in pediatrics treatment (author's transl)].
    Motohiro T, Takechi T, Soejima N, Watari H, Oohashi K, Sakata Y, Nishiyama T, Ezaki Y, Yokoyama T, Nakajima T, Komatsu Y, Ishimoto K, Tominaga K, Yamashita F, Takeya S, Yamamoto M, Ohkita R, Iriki T.
    Jpn J Antibiot; 1980 Sep; 33(9):943-58. PubMed ID: 6452544
    [Abstract] [Full Text] [Related]

  • 14. [Pharmacokinetic and clinical evaluation of tazobactam/piperacillin in the pediatric field].
    Toyonaga Y, Ishihara T, Tezuka T, Nakamura H.
    Jpn J Antibiot; 1998 May; 51(5):325-45. PubMed ID: 9693966
    [Abstract] [Full Text] [Related]

  • 15. [Antibacterial action of cefoperazone and piperacillin against Escherichia coli].
    Obana Y, Nishino T, Tanino T.
    Jpn J Antibiot; 1983 Feb; 36(2):249-59. PubMed ID: 6222209
    [Abstract] [Full Text] [Related]

  • 16. [Excretion of antibiotics into bile and urine in patients with external cholecystostomy done in order to treat obstructive jaundice].
    Hidaka K, Yamamoto H, Harada S, Katano M, Fujiwara H, Mizoguchi T, Hisatsugu T, Yamaoka K, Kisu T.
    Jpn J Antibiot; 1988 Sep; 41(9):1295-303. PubMed ID: 3241327
    [Abstract] [Full Text] [Related]

  • 17. [Basic and clinical studies on tazobactam/piperacillin in pediatric field].
    Motohiro T, Nagai K, Yamada T, Oki S, Yamada T, Yoshinaga Y, Tsumura N, Oda K, Sakata Y, Kato H, Imai S, Morita J, Matsuo Y, Ikezawa S, Takahgashi K, Fukuda T, Yamashita Y, Aramaki M, Hayashi M, Yamakawa R, Ono-E, Tananari Y, Tsutsumi T, Hoshuyama A, Aida K.
    Jpn J Antibiot; 1998 Jun; 51(6):413-31. PubMed ID: 9755831
    [Abstract] [Full Text] [Related]

  • 18. [Fundamental and clinical studies of sulbactam/cefoperazone in the field of pediatrics].
    Nakazawa S, Sato H, Narita A, Nakazawa S, Suzuki H, Chikaoka H, Tazoe K.
    Jpn J Antibiot; 1984 Nov; 37(11):2174-87. PubMed ID: 6098710
    [Abstract] [Full Text] [Related]

  • 19. [Safety and pharmacology of aspoxicillin in healthy volunteers].
    Matsumoto K, Shishido H, Uzuka Y, Nagatake T, Yamamoto M, Sakuma Y, Maezawa I, Yamaguchi T.
    Jpn J Antibiot; 1985 Oct; 38(10):2699-715. PubMed ID: 4078992
    [Abstract] [Full Text] [Related]

  • 20. [Pharmacokinetic, bacteriological and clinical evaluation of tazobactam/piperacillin in pediatrics].
    Iwai N, Nakamura H, Miyazu M.
    Jpn J Antibiot; 1998 May; 51(5):346-61. PubMed ID: 9693967
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.